A case series of Monoclonal Gammopathy of Undetermined Significance and COVID‐19
Open Access
- 24 June 2020
- journal article
- letter
- Published by Wiley in British Journal of Haematology
- Vol. 190 (3) , E130-E133
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19New England Journal of Medicine, 2020
- Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital SystemCancer Discovery, 2020
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City AreaJAMA, 2020
- Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 OutbreakCancer Discovery, 2020
- Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysisAging, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- How I manage monoclonal gammopathy of undetermined significanceBlood, 2018
- Monoclonal gammopathy of undetermined significance and risk of infections: a population-based studyHaematologica, 2011
- Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myelomaBlood, 2008
- Pathogenesis and progression of monoclonal gammopathy of undetermined significanceLeukemia, 2008